The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Dementia, Multi-Infarct

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Dementia, Multi-Infarct


Psychiatry related information on Dementia, Multi-Infarct


High impact information on Dementia, Multi-Infarct


Chemical compound and disease context of Dementia, Multi-Infarct


Biological context of Dementia, Multi-Infarct


Anatomical context of Dementia, Multi-Infarct


Gene context of Dementia, Multi-Infarct


Analytical, diagnostic and therapeutic context of Dementia, Multi-Infarct


  1. An analysis of lymphocyte 3H-N-methyl-scopolamine binding in neurological patients. Evidence of altered binding in Alzheimer's disease. Ferrero, P., Rocca, P., Eva, C., Benna, P., Rebaudengo, N., Ravizza, L., Genazzani, E., Bergamasco, B. Brain (1991) [Pubmed]
  2. CSF somatostatin-like immunoreactivity in dementia. Beal, M.F., Growdon, J.H., Mazurek, M.F., Martin, J.B. Neurology (1986) [Pubmed]
  3. Dementia of different etiologies: vasoactive intestinal polypeptide in CSF. Wikkelsø, C., Fahrenkrug, J., Blomstrand, C., Johansson, B.B. Neurology (1985) [Pubmed]
  4. Circulating immune complexes in sera from patients with Alzheimer's disease, multi-infarct dementia and Down's syndrome. Heinonen, O., Syrjänen, S., Soininen, H., Talasniemi, S., Kaski, M., Mäntyjärvi, R., Syrjänen, K., Riekkinen, P. Neurosci. Lett. (1993) [Pubmed]
  5. Twenty-four-hour ambulatory electrocardiography in elderly subjects: prevalence of various arrhythmias and prognostic implications (report from the Bronx Longitudinal Aging Study). Frishman, W.H., Heiman, M., Karpenos, A., Ooi, W.L., Mitzner, A., Goldkorn, R., Greenberg, S. Am. Heart J. (1996) [Pubmed]
  6. CSF beta-endorphin and beta-lipotropin in Alzheimer's disease and multi-infarct dementia. Sulkava, R., Erkinjuntti, T., Laatikainen, T. Neurology (1985) [Pubmed]
  7. Topographic maps of brain electrical activity in primary degenerative dementia of the Alzheimer type and multiinfarct dementia. Martin-Loeches, M., Gil, P., Jimenez, F., Exposito, F.J., Miguel, F., Cacabelos, R., Rubia, F.J. Biol. Psychiatry (1991) [Pubmed]
  8. Elevated cerebrospinal fluid lactic acid levels in Creutzfeldt-Jakob disease. Awerbuch, G., Peterson, P., Sandyk, R. Int. J. Neurosci. (1988) [Pubmed]
  9. Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders. Lipton, S.A. J. Alzheimers Dis. (2004) [Pubmed]
  10. Multichannel EEG frequency analysis and somatosensory-evoked potentials in patients with different types of organic dementia. Rosén, I., Gustafson, L., Risberg, J. Dementia (1993) [Pubmed]
  11. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. Le Bars, P.L., Katz, M.M., Berman, N., Itil, T.M., Freedman, A.M., Schatzberg, A.F. JAMA (1997) [Pubmed]
  12. Autosomal dominant leukoencephalopathy and subcortical ischemic stroke. A clinicopathological study. Baudrimont, M., Dubas, F., Joutel, A., Tournier-Lasserve, E., Bousser, M.G. Stroke (1993) [Pubmed]
  13. Homovanillic acid and 5-hydroxyindoleacetic acid modifications in CSF of patients with stroke and multi-infarct dementia. Smirne, S., Franceschi, M., Truci, G., Camerlingo, M., Pirola, R., Ferini-Strambi, L., Bareggi, S.R. Stroke (1985) [Pubmed]
  14. CT-CBF correlations of cognitive deficits in multi-infarct dementia. Kitagawa, Y., Meyer, J.S., Tachibana, H., Mortel, K.F., Rogers, R.L. Stroke (1984) [Pubmed]
  15. The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia. Benson, D.F., Kuhl, D.E., Hawkins, R.A., Phelps, M.E., Cummings, J.L., Tsai, S.Y. Arch. Neurol. (1983) [Pubmed]
  16. Are thrombocyte membranes altered in Alzheimer's disease? A morphometric and biochemical study. Bosman, G.J., Schuurmans Stekhoven, J.H., Melenhorst, J.J., Van Zuylen, A.J., Bartholomeus, I.G., Van Kalmthout, P.J., De Grip, W.J. Neurobiol. Aging (1992) [Pubmed]
  17. Cyclandelate in the treatment of multi-infarct dementia. Interim findings from a multicentre study in general practice. Blakemore, C.B. Drugs (1987) [Pubmed]
  18. Single photon emission computerised tomography in elderly patients with Alzheimer's disease and multi-infarct dementia. Regional uptake of technetium-labelled HMPAO related to clinical measurements. McKeith, I.G., Bartholomew, P.H., Irvine, E.M., Cook, J., Adams, R., Simpson, A.E. The British journal of psychiatry : the journal of mental science. (1993) [Pubmed]
  19. Cerebral vasomotor responses during oxygen inhalation. Results in normal aging and dementia. Amano, T., Meyer, J.S., Okabe, T., Shaw, T., Mortel, K.F. Arch. Neurol. (1983) [Pubmed]
  20. Schizophrenia in a patient with cerebral autosomally dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL disease). Lågas, P.A., Juvonen, V. Nordic journal of psychiatry. (2001) [Pubmed]
  21. Age dependence of tissue plasminogen activator concentrations in plasma, as studied by an improved enzyme-linked immunosorbent assay. Rånby, M., Bergsdorf, N., Nilsson, T., Mellbring, G., Winblad, B., Bucht, G. Clin. Chem. (1986) [Pubmed]
  22. Cerebrospinal fluid neuron-specific enolase is decreased in multi-infarct dementia, but unchanged in Alzheimer's disease. Sulkava, R., Viinikka, L., Erkinjuntti, T., Roine, R. J. Neurol. Neurosurg. Psychiatr. (1988) [Pubmed]
  23. Loss of synaptophysin-like immunoreactivity in the hippocampal formation is an early phenomenon in Alzheimer's disease. Heinonen, O., Soininen, H., Sorvari, H., Kosunen, O., Paljärvi, L., Koivisto, E., Riekkinen, P.J. Neuroscience (1995) [Pubmed]
  24. Blood-brain barrier in Alzheimer dementia and in non-demented elderly. An immunocytochemical study. Alafuzoff, I., Adolfsson, R., Grundke-Iqbal, I., Winblad, B. Acta Neuropathol. (1987) [Pubmed]
  25. Positron emission tomography in the differential diagnosis of organic dementias. Heiss, W.D., Kessler, J., Szelies, B., Grond, M., Fink, G., Herholz, K. J. Neural Transm. Suppl. (1991) [Pubmed]
  26. Amyloid beta protein precursors with kunitz-type inhibitor domains and acetylcholinesterase in cerebrospinal fluid from patients with dementia of the Alzheimer type. Urakami, K., Takahashi, K., Saito, H., Okada, A., Nakamura, S., Tanaka, S., Kitaguchi, N., Tokushima, Y., Yamamoto, S. Acta neurologica Scandinavica. (1992) [Pubmed]
  27. Determination in human cerebrospinal fluid of glial fibrillary acidic protein, S-100 and myelin basic protein as indices of non-specific or specific central nervous tissue pathology. Noppe, M., Crols, R., Andries, D., Lowenthal, A. Clin. Chim. Acta (1986) [Pubmed]
  28. Inositol monophosphatase activity in normal, Down syndrome and dementia of the Alzheimer type CSF. Atack, J.R., Schapiro, M.B. Neurobiol. Aging (2002) [Pubmed]
  29. Neuroendocrine studies in dementia patients: responses of plasma GH and PRL following bromocriptine administration. Higashi, S., Fujita, M., Nishimoto, Y., Kuroda, K., Asaba, H., Sakai, T. Acta neurologica Scandinavica. (1994) [Pubmed]
  30. Serum and cerebrospinal fluid proteins and the blood-brain barrier in Alzheimer's disease and multi-infarct dementia. Elovaara, I., Palo, J., Erkinjuntti, T., Sulkava, R. Eur. Neurol. (1987) [Pubmed]
  31. Responders and non-responders to bifemelane hydrochloride in Alzheimer-type and multi-infarct dementia. Shigeta, M., Nishikawa, Y., Shimizu, M., Usui, M., Hyoki, K., Kawamuro, Y. International clinical psychopharmacology. (1993) [Pubmed]
  32. Effects of co-dergocrine mesylate (Hydergine) in multi-infarct dementia as evaluated by positron emission tomography. Nagasawa, H., Kogure, K., Kawashima, K., Ido, T., Itoh, M., Hatazawa, J. Tohoku J. Exp. Med. (1990) [Pubmed]
WikiGenes - Universities